Susquehanna International Group
LUMO

Susquehanna International Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Susquehanna International Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-97,800
Closed -$1.61M – 11282
2020
Q2 		$1.61M Sell
97,800
-200
-0.2% -$2.38K ﹤0.01% 4885
2020
Q1 		$833K Buy
98,000
+74,244
+313% +$1.04M ﹤0.01% 5800
2019
Q4 		$541K Buy
23,756
+6,778
+40% +$96.7K ﹤0.01% 6839
2019
Q3 		$243K Buy
+16,978
New +$249K ﹤0.01% 8722
2019
Q2 		– Sell
-2,678
Closed -$47K – 10962
2019
Q1 		$47K Buy
2,678
+1,422
+113% +$21.2K ﹤0.01% 8476
2018
Q4 		$17K Sell
1,256
-1,388
-52% -$24.4K ﹤0.01% 8701
2018
Q3 		$57K Sell
2,644
-29,045
-92% -$883K ﹤0.01% 8805
2018
Q2 		$1.36M Sell
31,689
-18,978
-37% -$869K ﹤0.01% 4743
2018
Q1 		$3.31M Buy
50,667
+25,911
+105% +$1.84M ﹤0.01% 3108
2017
Q4 		$1.81M Buy
24,756
+19,700
+390% +$1.63M ﹤0.01% 4080
2017
Q3 		$463K Buy
5,056
+2,378
+89% +$182K ﹤0.01% 6649
2017
Q2 		$177K Sell
2,678
-11,700
-81% -$1.45M ﹤0.01% 8379
2017
Q1 		$3.12M Sell
14,378
-3,155
-18% -$451K ﹤0.01% 2963
2016
Q4 		$1.62M Sell
17,533
-3,556
-17% -$401K ﹤0.01% 4509
2016
Q3 		$2.85M Sell
21,089
-689
-3% -$68.4K ﹤0.01% 2990
2016
Q2 		$2.21M Sell
21,778
-29,300
-57% -$3.63M ﹤0.01% 3403
2016
Q1 		$8.37M Buy
51,078
+25,011
+96% +$5.07M ﹤0.01% 1728
2015
Q4 		$8.54M Buy
26,067
+567
+2% +$185K ﹤0.01% 1914
2015
Q3 		$8.22M Sell
25,500
-5,856
-19% -$2.57M ﹤0.01% 2054
2015
Q2 		$12.5M Sell
31,356
-77,888
-71% -$33.1M 0.01% 1750
2015
Q1 		$53.8M Buy
109,244
+14,944
+16% +$5.79M 0.02% 591
2014
Q4 		$33.7M Buy
94,300
+22,544
+31% +$6.71M 0.01% 965
2014
Q3 		$13.8M Buy
71,756
+26,767
+59% +$5.88M 0.01% 1763
2014
Q2 		$10.8M Buy
44,989
+35,356
+367% +$7.19M ﹤0.01% 2040
2014
Q1 		$2.46M Sell
9,633
-9,311
-49% -$2.85M ﹤0.01% 3973
2013
Q4 		$3.75M Buy
18,944
+477
+3% +$84.8K ﹤0.01% 3337
2013
Q3 		$3.12M Buy
18,467
+9,267
+101% +$1.49M ﹤0.01% 3420
2013
Q2 		$1.63M Buy
+9,200
New +$1.3M ﹤0.01% 4219

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group's LUMO Position: Q3 2020 in Review

Susquehanna International Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2020, closing a stake of 11,381 shares — an estimated $188K sold.

Susquehanna International Group first reported a position in LUMO in Q2 2013 and held it in 24 quarters. The position peaked at $14.9M in Q1 2015. 38 funds tracked by Wall St. Rank hold LUMO as of Q3 2020.

  • Susquehanna International Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Susquehanna International Group sold 11,381 Lumos Pharma, Inc. Common Stock shares in Q3 2020, an estimated $188K.
  • Susquehanna International Group first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 24 quarters.
  • Susquehanna International Group's Lumos Pharma, Inc. Common Stock position peaked at $14.9M in Q1 2015.
  • 38 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2020.

Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.